| 前收市價 | 205.70 |
| 開市 | 207.31 |
| 買盤 | 0.00 x 800 |
| 賣出價 | 244.89 x 800 |
| 今日波幅 | 204.12 - 209.01 |
| 52 週波幅 | 180.93 - 348.67 |
| 成交量 | |
| 平均成交量 | 343,883 |
| 市值 | 7.979B |
| Beta 值 (5 年，每月) | 0.53 |
| 市盈率 (最近 12 個月) | 88.48 |
| 每股盈利 (最近 12 個月) | 2.33 |
| 業績公佈日 | 2024年5月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 277.38 |
ZacksPenumbra's (PEN) New Launch to Enhance Blood Clot Removal
Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
ZacksHere's Why You Should Retain Penumbra (PEN) Stock for Now
Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
ZacksPenumbra (PEN) Gains From Innovation, Mounting Costs Ail
Penumbra (PEN) expects to materially increase both revenues and profitability in the company's international business in the next three years and beyond.
